论文部分内容阅读
目的:分析米索前列醇预防剖宫产产后出血的临床效果。方法:选取我院2011年1月-2013年1月期间收治的80例足月剖宫产产妇,随机平均分为A、B两组。给予A组孕妇肌肉注射催产素,同时行静脉滴注催产素预防措施,给予B组孕妇口服或舌下含化米索前列醇预防措施,并在术后进行肛塞米索前列醇处理,对比两组孕妇临床预防效果。结果:两组对比,B组孕妇产后2 h、24 h出血量更少,产后出血发生率更低,差异显著,具有统计学意义(P<0.05)。两组产妇术前舒张压等差异无统计学意义(P>0.05);术后A组产妇生命体征较术前无显著变化,差异不具有统计学意义(P>0.05),B组产妇生命体征较术前差异不明显,不具有统计学意义(P>0.05)。结论:米索前列醇预防剖宫产产后出血临床效果显著,值得推广与应用。
Objective: To analyze the clinical effect of misoprostol in preventing bleeding after cesarean section. Methods: 80 cases of full-term cesarean section in our hospital from January 2011 to January 2013 were randomly divided into A and B groups. A group of pregnant women given intramuscular oxytocin, intravenous oxytocin intravenous prophylaxis at the same time, giving group B pregnant women oral or sublingual misoprostol precautionary measures, and after anal an misoprostol treatment, contrast Two groups of pregnant women clinical preventive effect. Results: Compared with the two groups, the pregnant women in group B had less bleeding at 24 h and less postpartum hemorrhage, the difference was statistically significant (P <0.05). There was no significant difference in preoperative diastolic blood pressure between the two groups (P> 0.05). The postoperative A group had no significant changes in vital signs compared with that before operation, the difference was not statistically significant (P> 0.05). The B group maternal vital signs Compared with the preoperative difference was not significant, not statistically significant (P> 0.05). Conclusion: Misoprostol is effective in preventing bleeding after cesarean section. It is worth popularizing and applying.